Overview

Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure

Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the safety and efficacy of intravenous infusion of carperitide using pressure measurements inside the heart and great vessels and measuring carperitide concentration in the blood.
Phase:
Phase 2
Details
Lead Sponsor:
Daiichi Sankyo Inc.
Daiichi Sankyo, Inc.